BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20952557)

  • 1. Medical surveillance programme for diisocyanate exposure.
    Labrecque M; Malo JL; Alaoui KM; Rabhi K
    Occup Environ Med; 2011 Apr; 68(4):302-7. PubMed ID: 20952557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures.
    Tarlo SM; Liss GM
    Appl Occup Environ Hyg; 2002 Dec; 17(12):902-8. PubMed ID: 12495601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence based guidelines for the prevention, identification, and management of occupational asthma.
    Tarlo SM; Liss GM
    Occup Environ Med; 2005 May; 62(5):288-9. PubMed ID: 15837848
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of occupational asthma in Ontario.
    Tarlo SM
    Can J Physiol Pharmacol; 2007 Jan; 85(1):167-72. PubMed ID: 17487256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in diisocyanate and non-diisocyanate sensitizer-induced occupational asthma in Ontario.
    Buyantseva LV; Liss GM; Ribeiro M; Manno M; Luce CE; Tarlo SM
    J Occup Environ Med; 2011 Apr; 53(4):420-6. PubMed ID: 21407095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with early detection of toluene diisocyanate-associated occupational asthma.
    Conner PR
    Appl Occup Environ Hyg; 2002 Dec; 17(12):856-62. PubMed ID: 12495596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment in workers with isocyanate-induced occupational asthma and removed from exposure in the province of Québec between 1985 and 2002.
    Labrecque M; Khemici E; Cartier A; Malo JL; Turcot J
    J Occup Environ Med; 2006 Oct; 48(10):1093-8. PubMed ID: 17033508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occupational asthma due to isocyanates: a study of 21 patients].
    Orriols R; Drobnic ME; Muñoz X; Rodrigo MJ; Morell F
    Med Clin (Barc); 1999 Nov; 113(17):659-62. PubMed ID: 10618782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of the "positive" methacholine challenge.
    Hewitt DJ
    Am J Ind Med; 2008 Oct; 51(10):769-81. PubMed ID: 18702111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometry and tests of bronchial hyperresponsiveness in population studies.
    Chan-Yeung M
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):633-8. PubMed ID: 10907766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS; Nahm DH
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of surveillance for isocyanate asthma: finding an occupational health policy framework.
    LaMontagne AD
    Occup Environ Med; 2005 Nov; 62(11):741-2. PubMed ID: 16234398
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance for isocyanate asthma: a model based cost effectiveness analysis.
    Wild DM; Redlich CA; Paltiel AD
    Occup Environ Med; 2005 Nov; 62(11):743-9. PubMed ID: 16234399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A system for the active surveillance of occupational bronchial asthma: the results of 2 years of activity of the PRiOR program].
    Bena A; D'Errico A; Mirabelli D
    Med Lav; 1999; 90(4):556-71. PubMed ID: 10522107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational asthma prevention and management in industry--an example of a global programme.
    Gannon PF; Berg AS; Gayosso R; Henderson B; Sax SE; Willems HM
    Occup Med (Lond); 2005 Dec; 55(8):600-5. PubMed ID: 16314331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course of isocyanate-induced asthma in relation to exposure cessation: longitudinal study of 50 subjects].
    Valentino M; Rapisarda V
    G Ital Med Lav Ergon; 2002; 24(1):26-31. PubMed ID: 11892412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma].
    Marabini A; Brugnami G; Curradi F; Severini C; Siracusa A
    Med Lav; 1994; 85(2):134-41. PubMed ID: 8072441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotrienes and isocyanate-induced asthma: a pilot study.
    Lemiere C; Pelissier S; Tremblay C; Chaboillez S; Thivierge M; Stankova J; Rola-Pleszczynski M
    Clin Exp Allergy; 2004 Nov; 34(11):1684-9. PubMed ID: 15544591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity.
    Malo JL; Cardinal S; Ghezzo H; L'Archevêque J; Castellanos L; Maghni K
    Clin Exp Allergy; 2011 Apr; 41(4):497-504. PubMed ID: 21114694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in occupational asthma in Belgium.
    Vandenplas O; Lantin AC; D'Alpaos V; Larbanois A; Hoet P; Vandeweerdt M; Thimpont J; Speybroeck N
    Respir Med; 2011 Sep; 105(9):1364-72. PubMed ID: 21624825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.